I

Innova Captab Ltd
NSE:INNOVACAP

Watchlist Manager
Innova Captab Ltd
NSE:INNOVACAP
Watchlist
Price: 1 015.35 INR 4.81% Market Closed
Market Cap: 58.1B INR
Have any thoughts about
Innova Captab Ltd?
Write Note

Innova Captab Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Innova Captab Ltd
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
I
Innova Captab Ltd
NSE:INNOVACAP
Current Portion of Long-Term Debt
â‚ą107.4m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Current Portion of Long-Term Debt
â‚ą10m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Suven Life Sciences Ltd
NSE:SUVEN
Current Portion of Long-Term Debt
â‚ą2.4m
CAGR 3-Years
-39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dishman Carbogen Amcis Ltd
NSE:DCAL
Current Portion of Long-Term Debt
â‚ą17.8B
CAGR 3-Years
213%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Current Portion of Long-Term Debt
â‚ą1.1B
CAGR 3-Years
93%
CAGR 5-Years
81%
CAGR 10-Years
N/A
Tarsons Products Ltd
NSE:TARSONS
Current Portion of Long-Term Debt
â‚ą24.9m
CAGR 3-Years
839%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Innova Captab Ltd
Glance View

Market Cap
58.1B INR
Industry
Life Sciences Tools & Services

Innova Captab Ltd is a IN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Panchkula, Haryana. The company went IPO on 2023-12-29. Innova Captab Ltd is an integrated pharmaceutical company. The firm is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The company has presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes CDMO business, domestic branded generics business, and international branded generic product business. Its CDMO business provides research, product development and manufacturing services. Its branded generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. The company has developed a diversified branded generics product portfolio including Tablets, capsules, dry syrups, dry powder injection, ointments and liquid orals.

INNOVACAP Intrinsic Value
779.06 INR
Overvaluation 23%
Intrinsic Value
Price
I

See Also

What is Innova Captab Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
107.4m INR

Based on the financial report for Mar 31, 2024, Innova Captab Ltd's Current Portion of Long-Term Debt amounts to 107.4m INR.

What is Innova Captab Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
23%

Over the last year, the Current Portion of Long-Term Debt growth was 209%. The average annual Current Portion of Long-Term Debt growth rates for Innova Captab Ltd have been 23% over the past three years .

Back to Top